NOA1
gene geneOn this page
Also known as MGC3232hAtNOS1hNOA1MTG3
Summary
NOA1 (nitric oxide associated 1, HGNC:28473) is a protein-coding gene on chromosome 4q12, encoding Nitric oxide-associated protein 1 (Q8NC60). Involved in regulation of mitochondrial protein translation and respiration. It is a selective cancer dependency (DepMap: 19.5% of cell lines).
The protein encoded by this gene is a nuclear-encoded GTPase that functions in the mitochondrion. Upon translation, this protein is imported into the nucleus and then into the nucleolus before being exported to the mitochondrion. The encoded protein is required for oxygen-dependent regulation of mitochondrial respiratory complexes and for mitochondrial protein synthesis.
Source: NCBI Gene 84273 — RefSeq curated summary.
At a glance
- GWAS associations: 11
- Clinical variants (ClinVar): 124 total
- Cancer dependency (DepMap): dependent in 19.5% of screened cell lines
- MANE Select transcript:
NM_032313
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28473 |
| Approved symbol | NOA1 |
| Name | nitric oxide associated 1 |
| Location | 4q12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC3232, hAtNOS1, hNOA1, MTG3 |
| Ensembl gene | ENSG00000084092 |
| Ensembl biotype | protein_coding |
| OMIM | 614919 |
| Entrez | 84273 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 7 protein_coding
ENST00000264230, ENST00000904429, ENST00000904430, ENST00000904431, ENST00000904432, ENST00000904433, ENST00000933297
RefSeq mRNA: 1 — MANE Select: NM_032313
NM_032313
CCDS: CCDS3510
Canonical transcript exons
ENST00000264230 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001032846 | 56973148 | 56973353 |
| ENSE00001032848 | 56973858 | 56974022 |
| ENSE00001032858 | 56964406 | 56964526 |
| ENSE00001074715 | 56966620 | 56966736 |
| ENSE00001074718 | 56968384 | 56968515 |
| ENSE00001074719 | 56976442 | 56977606 |
| ENSE00001074722 | 56963350 | 56963661 |
Expression profiles
Bgee: expression breadth ubiquitous, 238 present calls, max score 95.32.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 28.7500 / max 161.5346, expressed in 1810 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 52229 | 24.3554 | 1807 |
| 52227 | 2.4845 | 1394 |
| 52228 | 1.0804 | 706 |
| 52230 | 0.8297 | 612 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibialis anterior | UBERON:0001385 | 95.32 | silver quality |
| ileal mucosa | UBERON:0000331 | 93.92 | gold quality |
| upper leg skin | UBERON:0004262 | 92.41 | gold quality |
| upper arm skin | UBERON:0004263 | 92.40 | gold quality |
| bronchial epithelial cell | CL:0002328 | 90.02 | gold quality |
| body of pancreas | UBERON:0001150 | 89.90 | gold quality |
| cortical plate | UBERON:0005343 | 89.56 | gold quality |
| deltoid | UBERON:0001476 | 89.54 | silver quality |
| parotid gland | UBERON:0001831 | 89.50 | gold quality |
| gastrocnemius | UBERON:0001388 | 89.49 | gold quality |
| bronchus | UBERON:0002185 | 89.48 | gold quality |
| muscle of leg | UBERON:0001383 | 89.03 | gold quality |
| jejunal mucosa | UBERON:0000399 | 88.98 | gold quality |
| skin of hip | UBERON:0001554 | 88.49 | gold quality |
| quadriceps femoris | UBERON:0001377 | 88.38 | gold quality |
| oral cavity | UBERON:0000167 | 87.84 | gold quality |
| tibia | UBERON:0000979 | 87.76 | gold quality |
| biceps brachii | UBERON:0001507 | 87.63 | gold quality |
| pancreas | UBERON:0001264 | 87.60 | gold quality |
| duodenum | UBERON:0002114 | 87.58 | gold quality |
| monocyte | CL:0000576 | 87.55 | gold quality |
| leukocyte | CL:0000738 | 87.53 | gold quality |
| mammalian vulva | UBERON:0000997 | 87.48 | gold quality |
| vastus lateralis | UBERON:0001379 | 87.45 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 87.35 | gold quality |
| parietal pleura | UBERON:0002400 | 86.98 | gold quality |
| oviduct epithelium | UBERON:0004804 | 86.78 | gold quality |
| secondary oocyte | CL:0000655 | 86.65 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 86.55 | gold quality |
| embryo | UBERON:0000922 | 86.46 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.29 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
12 targeting NOA1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-516B-5P | 99.56 | 66.33 | 1495 |
| HSA-MIR-582-5P | 99.47 | 70.79 | 2635 |
| HSA-MIR-889-3P | 99.40 | 69.76 | 2103 |
| HSA-MIR-6827-5P | 98.46 | 64.88 | 1256 |
| HSA-MIR-124-5P | 98.11 | 67.65 | 1095 |
| HSA-MIR-6726-5P | 95.97 | 63.72 | 841 |
| HSA-MIR-920 | 95.97 | 63.95 | 811 |
| HSA-MIR-555 | 95.92 | 65.25 | 564 |
| HSA-MIR-4300 | 95.85 | 64.56 | 1003 |
| HSA-MIR-5591-5P | 95.85 | 64.76 | 1002 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 19.5% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 3)
- The present study suggests a novel function for mAtNOS1 in regulating mitochondrial nitric oxide and calcium and inducing apoptosis of MCF-7 cells (PMID:18456285)
- This study indicates rhat C4orf14 is involved in 28S subunit biogenesis and mtDNA maintenance. (PMID:22447445)
- Our results uncovered an unexpected, mandatory detour of NOA1 through the nucleolus before uptake into mitochondria. (PMID:25072814)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | noa1 | ENSDARG00000102934 |
| mus_musculus | Noa1 | ENSMUSG00000036285 |
| rattus_norvegicus | Noa1 | ENSRNOG00000002055 |
| drosophila_melanogaster | CG10914 | FBGN0034307 |
| caenorhabditis_elegans | WBGENE00013001 |
Paralogs (6): LSG1 (ENSG00000041802), GNL3L (ENSG00000130119), GNL2 (ENSG00000134697), MTG1 (ENSG00000148824), GNL3 (ENSG00000163938), GNL1 (ENSG00000204590)
Protein
Protein identifiers
Nitric oxide-associated protein 1 — Q8NC60 (reviewed: Q8NC60)
All UniProt accessions (1): Q8NC60
UniProt curated annotations — full annotation on UniProt →
Function. Involved in regulation of mitochondrial protein translation and respiration. Plays a role in mitochondria-mediated cell death. May act as a scaffolding protein or stabilizer of respiratory chain supercomplexes. Binds GTP.
Subunit / interactions. Homodimer or multimer. Interacts with mitochondrial complex I, DAP3, MRPL12 and MRPS27.
Subcellular location. Mitochondrion inner membrane.
Similarity. Belongs to the TRAFAC class YlqF/YawG GTPase family. NOA1 subfamily.
RefSeq proteins (1): NP_115689* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006073 | GTP-bd | Domain |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR030378 | G_CP_dom | Domain |
| IPR048422 | NOA1/YqeH-like_C | Domain |
| IPR052807 | Mito_transl_resp_regulator | Family |
Pfam: PF01926, PF21516
UniProt features (55 total): strand 22, helix 17, sequence conflict 3, region of interest 3, turn 3, sequence variant 3, chain 1, domain 1, compositionally biased region 1, modified residue 1
Structure
Experimental structures (PDB)
5 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8CSP | ELECTRON MICROSCOPY | 2.66 |
| 9H54 | ELECTRON MICROSCOPY | 3 |
| 9H51 | ELECTRON MICROSCOPY | 3.1 |
| 9G5B | ELECTRON MICROSCOPY | 3.2 |
| 9H55 | ELECTRON MICROSCOPY | 3.4 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NC60-F1 | 74.04 | 0.30 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 77
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 94 (showing top):
GOBP_RIBOSOME_BIOGENESIS, TGCGCANK_UNKNOWN, BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN, GOBP_RIBOSOME_ASSEMBLY, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS, GOBP_PROTEIN_RNA_COMPLEX_ORGANIZATION, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_ORGANELLE_ASSEMBLY, ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN, IK3_01, HEIDENBLAD_AMPLICON_12P11_12_DN, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, GOBP_RIBOSOMAL_SMALL_SUBUNIT_ASSEMBLY, GOCC_LUMENAL_SIDE_OF_MEMBRANE
GO Biological Process (4): apoptotic process (GO:0006915), mitochondrion organization (GO:0007005), mitochondrial ribosome assembly (GO:0061668), mitochondrial small ribosomal subunit assembly (GO:0180026)
GO Molecular Function (5): RNA binding (GO:0003723), GTP binding (GO:0005525), RNA folding chaperone (GO:0140691), nucleotide binding (GO:0000166), protein binding (GO:0005515)
GO Cellular Component (5): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial matrix (GO:0005759), membrane (GO:0016020), matrix side of mitochondrial inner membrane (GO:0099617)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| programmed cell death | 1 |
| apoptotic signaling pathway | 1 |
| execution phase of apoptosis | 1 |
| organelle organization | 1 |
| ribosome assembly | 1 |
| ribosomal small subunit assembly | 1 |
| mitochondrial ribosome assembly | 1 |
| nucleic acid binding | 1 |
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| molecular_function | 1 |
| RNA folding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| mitochondrion | 1 |
| intracellular organelle lumen | 1 |
| cellular anatomical structure | 1 |
| mitochondrial inner membrane | 1 |
| lumenal side of membrane | 1 |
Protein interactions and networks
STRING
2859 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NOA1 | MTG2 | Q9H4K7 | 869 |
| NOA1 | MTG1 | Q9BT17 | 822 |
| NOA1 | ERAL1 | O75616 | 776 |
| NOA1 | POLR2B | P30876 | 666 |
| NOA1 | MALSU1 | Q96EH3 | 653 |
| NOA1 | GTPBP10 | A4D1E9 | 646 |
| NOA1 | TFAM | Q00059 | 605 |
| NOA1 | NSUN4 | Q96CB9 | 592 |
| NOA1 | MRPS7 | Q9Y2R9 | 589 |
| NOA1 | MTERF4 | Q7Z6M4 | 576 |
| NOA1 | IGFBP7 | Q16270 | 559 |
| NOA1 | DAP3 | P51398 | 544 |
| NOA1 | GTPBP8 | Q8N3Z3 | 535 |
| NOA1 | DDX28 | Q9NUL7 | 527 |
| NOA1 | GTPBP6 | O43824 | 505 |
IntAct
126 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PKMYT1 | CCNB2 | psi-mi:“MI:0914”(association) | 0.730 |
| DAP3 | NOA1 | psi-mi:“MI:0915”(physical association) | 0.700 |
| NOA1 | DAP3 | psi-mi:“MI:0407”(direct interaction) | 0.700 |
| KLHL22 | TMEM223 | psi-mi:“MI:0914”(association) | 0.640 |
| MRPS27 | MRPS14 | psi-mi:“MI:0914”(association) | 0.640 |
| LIN28A | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.640 |
| MRPS6 | STAT5A | psi-mi:“MI:0914”(association) | 0.550 |
| MRPS15 | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| TRMT10B | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| CBX6 | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS18B | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB2 | POLRMT | psi-mi:“MI:0914”(association) | 0.530 |
| CCDC59 | GAPDHS | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS34 | ZZEF1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS18C | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| NOA1 | ATE1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS15 | PRKACG | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS27 | YBX1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS34 | MRPS12 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS11 | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| LIN28B | ELAVL2 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS26 | MRPS10 | psi-mi:“MI:0914”(association) | 0.530 |
| NOA1 | NDUFA9 | psi-mi:“MI:0915”(physical association) | 0.500 |
| NDUFAB1 | MIEF1 | psi-mi:“MI:0915”(physical association) | 0.490 |
| AURKAIP1 | NRDC | psi-mi:“MI:0914”(association) | 0.480 |
BioGRID (123): NOA1 (Affinity Capture-MS), NOA1 (Affinity Capture-MS), NOA1 (Affinity Capture-MS), NOA1 (Affinity Capture-MS), NOA1 (Affinity Capture-MS), NOA1 (Affinity Capture-MS), NOA1 (Affinity Capture-MS), NOA1 (Affinity Capture-MS), NOA1 (Affinity Capture-MS), NOA1 (Affinity Capture-MS), NOA1 (Affinity Capture-MS), NOA1 (Affinity Capture-MS), NOA1 (Affinity Capture-MS), NOA1 (Proximity Label-MS), NOA1 (Affinity Capture-MS)
ESM2 similar proteins: A0JNU3, A1L1F1, A2AIL4, A4IHH4, A4QP75, B3MGZ0, B4GGT6, F6ZFR0, O00746, O08776, O55137, O55171, O88202, O88267, P36776, P49753, P87355, Q28CM7, Q32LB9, Q330K2, Q3B8B2, Q3T056, Q4R816, Q4VK78, Q566Y1, Q58DL1, Q59HJ6, Q5EBA1, Q5RJV0, Q6DFN1, Q80YD1, Q810S1, Q86U10, Q8BWN8, Q8CGK3, Q8HY87, Q8NC60, Q924S5, Q96BQ1, Q99KK9
Diamond homologs: Q32LB9, Q8NC60, Q9JJG9, Q8W4I6
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 130 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial ribosome-associated quality control | 23 | 32.1× | 1e-26 |
| Mitochondrial translation initiation | 21 | 30.3× | 6e-24 |
| Mitochondrial translation elongation | 21 | 30.3× | 6e-24 |
| Mitochondrial translation | 19 | 29.7× | 2e-21 |
| Mitochondrial translation termination | 21 | 26.2× | 1e-22 |
| Translation | 20 | 14.1× | 5e-16 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 22 | 32.4× | 7e-25 |
| translation | 13 | 11.3× | 4e-08 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
124 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 97 |
| Likely benign | 17 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1266 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:56964530:CCAA:C | acceptor_gain | 1.0000 |
| 4:56964531:C:CT | acceptor_gain | 1.0000 |
| 4:56964532:A:T | acceptor_gain | 1.0000 |
| 4:56964533:A:AC | acceptor_gain | 1.0000 |
| 4:56964533:A:C | acceptor_gain | 1.0000 |
| 4:56964538:A:AC | acceptor_gain | 1.0000 |
| 4:56973142:ACAT:A | donor_loss | 1.0000 |
| 4:56973144:ATACA:A | donor_loss | 1.0000 |
| 4:56973145:TA:T | donor_loss | 1.0000 |
| 4:56973146:A:AC | donor_gain | 1.0000 |
| 4:56973146:A:C | donor_loss | 1.0000 |
| 4:56973147:C:CC | donor_gain | 1.0000 |
| 4:56973147:CA:C | donor_gain | 1.0000 |
| 4:56973147:CACA:C | donor_gain | 1.0000 |
| 4:56973147:CACAA:C | donor_gain | 1.0000 |
| 4:56973350:CTTC:C | acceptor_gain | 1.0000 |
| 4:56973352:TCCT:T | acceptor_loss | 1.0000 |
| 4:56973353:CCTAG:C | acceptor_loss | 1.0000 |
| 4:56973354:C:CC | acceptor_gain | 1.0000 |
| 4:56973354:CT:C | acceptor_loss | 1.0000 |
| 4:56973355:T:G | acceptor_loss | 1.0000 |
| 4:56973853:CTTA:C | donor_loss | 1.0000 |
| 4:56973856:A:AT | donor_loss | 1.0000 |
| 4:56973857:C:CG | donor_loss | 1.0000 |
| 4:56973857:CCTA:C | donor_gain | 1.0000 |
| 4:56974021:ACCTG:A | acceptor_loss | 1.0000 |
| 4:56974023:C:T | acceptor_loss | 1.0000 |
| 4:56974024:T:C | acceptor_loss | 1.0000 |
| 4:56963658:CAAC:C | acceptor_gain | 0.9900 |
| 4:56963659:AACC:A | acceptor_loss | 0.9900 |
AlphaMissense
4491 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:56976534:T:A | K351I | 0.997 |
| 4:56976635:G:C | S317R | 0.997 |
| 4:56976635:G:T | S317R | 0.997 |
| 4:56976637:T:G | S317R | 0.997 |
| 4:56973997:A:C | F390L | 0.996 |
| 4:56973997:A:T | F390L | 0.996 |
| 4:56973999:A:G | F390L | 0.996 |
| 4:56976840:T:A | K249I | 0.996 |
| 4:56973176:T:G | D496A | 0.995 |
| 4:56976505:A:G | S361P | 0.994 |
| 4:56963659:A:G | W630R | 0.993 |
| 4:56963659:A:T | W630R | 0.993 |
| 4:56968400:C:G | R544P | 0.993 |
| 4:56973175:G:C | D496E | 0.993 |
| 4:56973175:G:T | D496E | 0.993 |
| 4:56973176:T:C | D496G | 0.993 |
| 4:56976521:A:C | F355L | 0.993 |
| 4:56976521:A:T | F355L | 0.993 |
| 4:56976523:A:G | F355L | 0.993 |
| 4:56976633:G:T | A318D | 0.993 |
| 4:56973176:T:A | D496V | 0.992 |
| 4:56973177:C:G | D496H | 0.992 |
| 4:56973958:C:A | R403S | 0.992 |
| 4:56973958:C:G | R403S | 0.992 |
| 4:56973998:A:G | F390S | 0.992 |
| 4:56976531:G:A | S352F | 0.992 |
| 4:56976842:G:C | N248K | 0.991 |
| 4:56976842:G:T | N248K | 0.991 |
| 4:56973959:C:G | R403T | 0.990 |
| 4:56976532:A:G | S352P | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000036418 (4:56973740 T>G), RS1000087036 (4:56974326 G>T), RS1000148356 (4:56978691 A>G), RS1000277479 (4:56967035 T>G), RS1000454733 (4:56978308 C>T), RS1000691560 (4:56967268 T>A), RS1001064612 (4:56966029 T>C), RS1001347204 (4:56964827 G>A,T), RS1001414043 (4:56966283 C>T), RS1001521554 (4:56970868 T>G), RS1001657776 (4:56974400 C>G,T), RS1001802904 (4:56969725 A>T), RS1001966351 (4:56962991 G>A,C), RS10032625 (4:56963048 C>G,T), RS1003270368 (4:56976167 C>G)
Disease associations
OMIM: gene MIM:614919 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
11 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000882_3 | Response to bleomycin (chromatid breaks) | 9.000000e-07 |
| GCST001232_2 | Age-related macular degeneration | 2.000000e-08 |
| GCST002647_24 | Height | 7.000000e-17 |
| GCST003116_1 | Coronary artery disease | 5.000000e-08 |
| GCST004787_2 | Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) | 8.000000e-08 |
| GCST005195_148 | Coronary artery disease | 1.000000e-08 |
| GCST005196_116 | Coronary artery disease | 2.000000e-09 |
| GCST005991_80 | Platelet count | 2.000000e-11 |
| GCST007329_5 | Automobile speeding propensity | 1.000000e-10 |
| GCST008163_175 | Height | 1.000000e-07 |
| GCST90002397_9 | Mean spheric corpuscular volume | 1.000000e-10 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007593 | chromatid break measurement |
| EFO:0004309 | platelet count |
| EFO:0008579 | risk-taking behaviour |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | increases expression, decreases expression | 2 |
| sodium arsenite | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| ICG 001 | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzophenoneidum | increases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Diazinon | increases methylation | 1 |
| Naled | affects expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Smoke | decreases expression | 1 |
| Tamoxifen | increases activity | 1 |
| Tretinoin | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Vitamin K 3 | affects expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.